The Food and Drug Administration has accepted a Biologics License Application for the investigational migraine prevention treatment, galcanezumab.
A recently published article exposes a gaping hole in the access to an effective first-line therapy for a portion of patients with cluster headache in the United States.
The stimulation of the transient receptor potential vanilloid 1 receptor may explain the benefits of capsaicin and hot water hydrotherapy in patients experiencing cannabinoid hyperemesis syndrome.
The FDA approved Duzallo, a fixed-dose tablet combining lesinurad and allopurinol, for the treatment of uncontrolled gout.
Diclofenac at 150 mg/day is the most effective NSAID for treating osteoarthritic pain and physical disability, while paracetamol had nearly no effect.
Boehringer Ingelheim has initiated a clinical study to investigate the interchangeability between an adalimumab biosimilar candidate and Humira.
Sequoia Sciences announced that the FDA has granted Fast Track Designation to its investigational vaccine for recurrent urinary tract infections caused by multi-drug resistant bacteria.
Primary care physicians can face many challenges in diagnosing conversion disorder; Dr Patricia Tsui sheds light on diagnosis and management in the primary care setting.
Etanercept therapy reduces clinical markers of disease activity in patients with psoriatic arthritis while stabilizing cardiovascular disease risk factors over a period of 5 years.
gammaCore, a hand-held device for treating episodic cluster headaches via mild electrical stimulation of the vagus nerve is now available in the United States.
Vaccinating against hepatitis B virus infection reduces the risk of non-Hodgkin lymphoma in adolescents.
Remote electrical stimulation is an effective, noninvasive, nonpharmacologic alternative treatment to traditional medications for acute migraine.
The American Diabetes Association released an updated position statement on the prevention, detection, and management of diabetic neuropathies.
There is little evidence to support the utility of biomarkers to guide clinical care for optimal RA treatment.
A research group developed the algorithm through a year-long process of reviewing data, sharing their own clinical experiences, and considering feedback from geriatric and pain societies.
Understanding pain mechanisms for targeted treatments.
Studies describing novel treatment avenues and/or complementary and alternative medicines for the treatment of pain in Parkinson's disease.
The Identification of Pain in Mood Disorders: Toward Improving Comorbid Diagnoses and Treatment OutcomesJune 27, 2016
Studies examining the identification and use of screening tools for mental illness in chronic pain
New guidelines for treatment of migraine in the ED seek to reduce opioid prescription.
Clinical Pain Advisor Articles
- Replacing Sleep, Sedentary Behavior With Physical Activity Beneficial in Knee Osteoarthritis
- The Role of Psychological Factors in Phantom Limb Pain Reviewed
- FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis
- Ozone vs Corticosteroids May Provide Longer-Lasting Effects for Plantar Fasciitis
- Opioid Use Stable in Past Decade Among Commercially Insured, Medicare Beneficiaries
- Ketamine: Mechanisms of Action, Uses in Pain Medicine, and Side Effects
- Cannabis May Be Effective for Migraine Treatment
- Medicinal Cannabis May Not Have Opioid-Sparing Effects in Chronic Noncancer Pain
- Integrating Psychological Interventions Into Chronic Pain Management
- Chronic Neck Pain: Generators, Clinical Examination, MRI Findings, and Differential Diagnosis
- Pregabalin May Not Improve Analgesia During Medical Abortion
- Investigational Treatment Shows Promise in Chronic Low Back Pain
- Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis
- Incorporating Guidelines Into Clinical Practice: An Interview With Gary L. LeRoy, MD
- Pain Severity May Partly Mediate the Association Between Depression and Physical Performance in Knee OA